Showing results (1701-1710 of 1,715) with videos related to

Sort By:
Pageof 172
The Journal of Clinical Investigation|October 12, 2023
Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumenYe Yang, Anne P Beigneux, Wenxin Song, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 30, 2024
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomesYan-Jun Xiang, Kang Wang, Ying-Yi Qin, et al.
International Journal of Cardiology|May 9, 2013
A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarctionLian R Gao, Xue T Pei, Qing A Ding, et al.
Journal of Medicinal Chemistry|September 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 MutationsTian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, et al.
Nature|July 15, 2026
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinomaQi Zhang, Qihan Fu, Yinan Shen, et al.
Plos One|February 6, 2013
Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern ChinaMin Lin, Ying-Fang Wen, Jiao-Ren Wu, et al.
American Journal of Human Genetics|June 18, 2019
RINT1 Bi-allelic Variations Cause Infantile-Onset Recurrent Acute Liver Failure and Skeletal AbnormalitiesMargot A Cousin, Erin Conboy, Jian-She Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 24, 2023
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemiaShan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, et al.
Nature|December 18, 2024
Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageingQi Qu, Yan Chen, Yu Wang, et al.
Biomedical and Environmental Sciences : BES|January 4, 2023
3- to 24-month Follow-up on COVID-19 with Pulmonary Tuberculosis Survivors after Discharge: Results from a Prospective, Multicenter StudyJing Ya Wang, Xing Yu Zong, Gui Hui Wu, et al.
Pageof 172